Sclerodoma

 

Sclerodoma

The excessive collagen deposition is a chronic disease that is indicative of a rare condition known as Scleroderma.  In the United States, at least 300,000 people will be impacted.  Women are four times more likely than males to have scleroderma.  Systemic sclerosis, often known as progressive systemic scleroderma, is a common and sometimes fatal condition.

The primary skin symptom of scleroderma is hardening of the skin with accompanying scarring. This will give the appearance of being scaly or reddish.  Additionally, blood vessels may have a tendency to be more noticeable.  When a greater area is impacted, there is waste of fat and muscle, which weakens the limbs and changes their look.  Scleroderma has the potential to impact blood vessels in the majority of severe cases.

The fact that scleroderma progresses between two cases makes it severe.  The most crucial information to have is the extent of internal attachment underneath the skin's surface as well as the entire area affected by the illness.  A person may be impacted by one or two lesions, or they may have several larger ones.  Raynaud's phenomenon, an arthritic vascular condition that can affect the fingers and toes, is common in scleroderma patients.  Because of the cold, the hands and feel could be discolored.  Systemic sclerosis and Raynaud's phenomenon can both lead to excruciating

ulcers also on the toes and fingers.  Calcium deposits around the joints are known as calcinosis, and they are frequently seen in people with systemic scleroderma close to the elbows, knees, or other joints.

Scleroderma comes in three main forms.  They are morphea, diffuse, limited, and occasionally referred to be linear.  Diffuse scleroderma type I is a systemic illness.  It is the most serious variation.  It is recognized that the rapid onset will result in increased skin hardening.  The lungs and digestive system will suffer significant internal organ damage as a result of diffuse scleroderma.  It poses a greater risk to life.

CREST syndrome is the term for restricted scleroderma, which is the second form.  Calcinosis, or Raynaud's Syndrome, is what the abbreviation CREST stands for.  Dysmotility of the esophagus Two of restricted scleroderma's five main symptoms are telangiectasia and sclerodactyly.  CREST is far milder and is a systemic disorder. It operates slowly.  Usually, only the face and hands experience skin hardening; internal organ processes are less severe.  For restricted scleroderma, the outlook is substantially better. 

While there is no known cure for this illness, some of its symptoms can be managed.  Medication to soften the skin and lessen edema will be part of these therapies.  For most patients, exposure to heat will also be beneficial.  You should discuss any details regarding this instance with your physician.